Roivant: The Next Telavant Has Arrived With Brepocitinib's Blockbuster Data (Rating Upgrade)

Roivant Sciences (ROIV) upgraded to Buy on strong Phase 2 BEACON data for brepocitinib; see pipeline upside, risks, and why ...